Chemical Management

Monitoring chemical recycling

April 13, 2022

Monitoring chemical
To reach environmental goals regarding climate change and the circular economy, the
recycling rate of plastics has to increase considerably over the coming years.

Spotlight

Cellectis

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 17 years of expertise in gene editing built on its flagship TALEN® technology and pioneering electroporation system PulseAgile Cellectis uses the power of the immune system to target and eradicate cancer cells. Using its life-science-focused, pioneering genome engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets. Cellectis is listed on the Nasdaq market (ticker: CLLS) and on the NYSE Alternext market.

OTHER WHITEPAPERS
news image

ADVANCED DEMAND FLEXIBILITY MANAGEMENT

whitePaper | June 22, 2022

California’s electricity system is undergoing rapid transformation on the pathway to 100% renewable power, with the expected high penetration of renewables, electrification of buildings and transportation, and deployment of behind-the-meter (BTM) distributed energy resources (DERs).

Read More
news image

Introduction to Edition II with comparative measurements

whitePaper | November 16, 2022

This white paper presents ABB’s new TSP341-N temperature sensor for non-invasive temperature measurement and provides examples for applications and accuracies that can be achieved.

Read More
news image

Boosting the performance of natural gas sweetening membrane plants

whitePaper | May 1, 2021

The performance of membrane separation processes is mainly driven by the specific separation performance of the membrane modules in addition to smart integration of this separation unit in the overall process design. The setup of membrane modules for polymeric membranes is often based on either flat sheets or hollow fibers. Given the one or the other concept, the implemented membrane material and separation layer thickness defines the maximum performance of the module with a supportive housing design. Thus, the ability to modify intrinsic properties of the polymer and the control of the membrane formation process are key factors to produce a superior membrane product. This is where competencies of a specialty chemicals company, i.e. Evonik, can contribute to unique membrane solutions for the market.

Read More
news image

CHARACTERIZING POSTCONSUMER RESIN WITHMATERIALS ANALYSIS

whitePaper | July 20, 2022

It’s impossible to think about plastics without picturing piles of soda bottles, filmy food wrappers, and other packaging floating in the ocean or washing up on the shore.

Read More
news image

Overview of Amazon Web Services

whitePaper | June 3, 2022

Amazon Web Services offers a broad set of global cloud-based products including compute, storage, databases, analytics, networking, mobile, developer tools,

Read More
news image

Decarbonizing the Canadian Chemical and Fertilizer Industry

whitePaper | March 11, 2023

Canada’s economy and the lives of Canadians are highly reliant on the materials and products produced by the chemical and fertilizer industry.

Read More

Spotlight

Cellectis

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 17 years of expertise in gene editing built on its flagship TALEN® technology and pioneering electroporation system PulseAgile Cellectis uses the power of the immune system to target and eradicate cancer cells. Using its life-science-focused, pioneering genome engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets. Cellectis is listed on the Nasdaq market (ticker: CLLS) and on the NYSE Alternext market.

Events